D013

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

DyslipidemiasHypertension

Phase 1

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

CompletedNCT03609606

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2018-08-09End: 2018-09-27Updated: 2018-10-05

Phase 3

Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2019-10-23End: 2021-04-30Target: 120Updated: 2020-05-14